1. Home
  2. CDNL vs NVAX Comparison

CDNL vs NVAX Comparison

Compare CDNL & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cardinal Infrastructure Group Inc. Class A Common Stock

CDNL

Cardinal Infrastructure Group Inc. Class A Common Stock

N/A

Current Price

$39.23

Market Cap

1.3B

Sector

N/A

ML Signal

N/A

Logo Novavax Inc.

NVAX

Novavax Inc.

N/A

Current Price

$8.07

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CDNL
NVAX
Founded
2013
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2025
1996

Fundamental Metrics

Financial Performance
Metric
CDNL
NVAX
Price
$39.23
$8.07
Analyst Decision
Strong Buy
Hold
Analyst Count
3
9
Target Price
$38.00
$11.33
AVG Volume (30 Days)
705.1K
3.0M
Earning Date
05-12-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
309.76
EPS
0.53
N/A
Revenue
$456,045,369.00
$1,123,479,000.00
Revenue This Year
$50.30
N/A
Revenue Next Year
$8.41
N/A
P/E Ratio
$74.38
N/A
Revenue Growth
44.69
64.69
52 Week Low
$21.98
$6.20
52 Week High
$96.40
$11.85

Technical Indicators

Market Signals
Indicator
CDNL
NVAX
Relative Strength Index (RSI) 29.83 50.94
Support Level $24.46 $7.70
Resistance Level $65.55 $10.10
Average True Range (ATR) 4.77 0.28
MACD -2.64 0.12
Stochastic Oscillator 13.99 87.68

Price Performance

Historical Comparison
CDNL
NVAX

About CDNL Cardinal Infrastructure Group Inc. Class A Common Stock

Cardinal Infrastructure Group Inc provides a comprehensive suite of infrastructure services to the residential, commercial, industrial, municipal, and state infrastructure markets. The company provides wet utility installations (water, sewer, and stormwater systems), as well as grading, site clearing, erosion control, drilling and blasting, paving, and other related site services. It derives all revenue in the United States of America from construction projects based in North Carolina and South Carolina.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: